Open AccessLive vaccines and immunosuppressive monoclonal antibodies: weighing up the benefit–risk assessment for natalizumab
Author(s) -
Jean-Marc Schwob,
Caroline Samer,
Patrice H. Lalive,
Gilles Éperon
Publication year - 2020
Publication title -
journal of travel medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.985
H-Index - 59
eISSN - 1708-8305
pISSN - 1195-1982
DOI - 10.1093/jtm/taaa235
Subject(s) - medicine , natalizumab , monoclonal antibody , virology , immunology , antibody , monoclonal , travel medicine , multiple sclerosis , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom